跳至主要内容
临床试验/NCT07754370
NCT07754370已完成4 期

Optimizing Initial Levothyroxine Dosing in Neonates With Congenital Hypothyroidism

Menoufia University1 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2025年11月2日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
101
试验地点
1
主要终点
Normalization of thyroid function after two weeks of treatment

研究概览

简要总结

This randomized controlled trial compared high-dose and moderate-dose levothyroxine as initial therapy for neonates with primary congenital hypothyroidism. One hundred one infants were randomized to receive either approximately 12.85 or 7.65 µg/kg/day. Thyroid function and dose adjustments were assessed every 2 weeks over the first six weeks of treatment to evaluate efficacy and safety.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
0 Days 至 28 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Neonates diagnosed with primary congenital hypothyroidism.
  • Full-term infants.
  • Newly diagnosed.
  • Treatment initiated during the neonatal period.
  • Written informed parental consent.

排除标准

  • Central congenital hypothyroidism.
  • Prematurity.
  • Major congenital malformations.
  • Serious systemic illness affecting thyroid function.
  • Previously thyroid hormone therapy.

结局指标

主要结局

Normalization of thyroid function after two weeks of treatment

时间窗: Two weeks

Comparison of serum TSH and free T4 between treatment groups after two weeks of levothyroxine therapy.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amira Fathy El-Fiky

Lecturer of pediatrics

Menoufia University

研究点 (1)

Loading locations...

相似试验